Financial Impact Of AET Withdrawing Its Individual Rate Filing Minimal

Analysts at Deutsche Bank maintain their "buy" rating on Aetna

. The target price for AET is set to $38. According to Deutsche Bank, “AET has pulled its Individual rate filing after math errors were discovered in the filings. AET was seeking an average rate increase of 19% on 65,000 Individual customers. After the earlier WLP (WellPoint) snafu, the state's actuary began a review of the filings submitted by Aetna & Blue Shield of California. The state also plans to review the filings for Health Net (HNT-Hold,CP 26.66 USD). AET found a "miscalculation not previously detected" when it conducted a 3rd round of internal reviews & that the error was based on "simple human error". The Insurance Commissioner now plans to post all new Individual rate filings on the department's website.” “While this is clearly a negative headline for Aetna, the financial impact should be modest to negligible…although expect the shares could experience some NT weakness on this development,” the analysts say.